No oral tirzepatide is FDA approved. Zepbound and Mounjaro are the only approved tirzepatide drugs, and both are weekly shots under the skin. Pills, drops and under-the-tongue tablets (ODT) sold as oral tirzepatide have no trial data we can cite. Start with our tirzepatide guide if you are new to the drug.
Key takeaways
- The Zepbound and Mounjaro labels describe one route only: subcutaneous injection in the abdomen, thigh or upper arm, once a week.
- Every tirzepatide trial in our verified list (SURMOUNT and SURPASS) used the injectable. None tested a pill, drop or sublingual form.
- The FDA warns that unapproved GLP-1 products, including compounded ones, are not reviewed for safety, effectiveness or quality.
- Compounded oral or sublingual tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro.
- If you want to avoid injections, the honest answer today is a conversation with a prescriber, not an oral tirzepatide product.
Does tirzepatide come in pill form?
Not as an approved medicine. Eli Lilly's tirzepatide is sold in two forms: a prefilled single-dose pen and a single-dose vial. Both are injected once weekly. The prescribing information for Zepbound and Mounjaro does not list a tablet, capsule, liquid, drop, film or sublingual product.
Tirzepatide is a peptide, a chain of 39 amino acids. Swallowed peptides meet stomach acid and digestive enzymes. That is why insulin, another peptide, is injected. Some companies are researching oral versions of GLP-1 class drugs, but no oral tirzepatide has been approved, and we do not have verified trial numbers for any oral tirzepatide, so this page does not print any.
Tirzepatide forms: what exists and what does not
| Form | Route | FDA status | Trial evidence in our list |
|---|---|---|---|
| Zepbound pen or vial | Subcutaneous injection, once weekly | FDA approved (chronic weight management; obstructive sleep apnea in adults with obesity) | SURMOUNT-1 through SURMOUNT-5, SURMOUNT-OSA |
| Mounjaro pen or vial | Subcutaneous injection, once weekly | FDA approved (type 2 diabetes) | SURPASS-1 through SURPASS-5 |
| Compounded tirzepatide vial | Subcutaneous injection | Not FDA approved | None |
| "Oral tirzepatide" tablet or capsule | Swallowed | Not FDA approved | None |
| Sublingual tirzepatide drops, tablets or ODT | Under the tongue | Not FDA approved | None |
Source: Zepbound and Mounjaro prescribing information (DailyMed); FDA, Concerns with Unapproved GLP-1 Drugs; PubMed entries for SURMOUNT-1 and SURPASS-1.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Does oral tirzepatide work? What the evidence says
We cannot say that it does, because there is no published trial of an oral, sublingual or ODT tirzepatide product in the sources we use. The weight loss people associate with tirzepatide comes from injection trials. In SURMOUNT-1, adults with obesity or overweight who used the injectable for 72 weeks had a mean weight change of -15.0% at 5 mg, -19.5% at 10 mg and -20.9% at 15 mg, against -3.1% for placebo. Those numbers belong to the injection. A pill or drop that has not been tested cannot borrow them.
A company selling sublingual tirzepatide may show you a certificate of analysis for the powder it started with. That tells you what went into the product. It does not tell you how much drug reaches your blood after you hold it under your tongue, or whether that amount is enough to reduce appetite. Only a pharmacokinetic study or a clinical trial can answer that, and none is in our verified list.
Oral tirzepatide reviews: why they are not evidence
Reviews of oral tirzepatide describe one person's experience with a product that has not been tested. Someone who takes drops and also cuts calories may lose weight for reasons that have nothing to do with the drops. The SURMOUNT-1 placebo group lost 3.1% of body weight over 72 weeks without any active drug. A review cannot separate the product from the placebo effect, the diet, or the natural variation between people. Trials exist to do that separation, and for oral tirzepatide those trials have not been published.
Oral tirzepatide vs injection: what the labeled product does
Because the injection is the only form with a label, here is what that label says about how it is used.
| Label item | Zepbound and Mounjaro injection |
|---|---|
| Starting dose | 2.5 mg once weekly for 4 weeks |
| Dose increases | In 2.5 mg steps after at least 4 weeks on the current dose |
| Maintenance doses | 5, 10 or 15 mg once weekly (Zepbound); maximum 15 mg |
| Timing | Any time of day, with or without meals |
| Missed dose | Take within 4 days; otherwise skip and resume on the regular day |
| Half-life | About 5 days; steady state after 4 weeks of weekly dosing |
| Storage | Refrigerate at 2 to 8 C; up to 21 days at up to 30 C; do not freeze |
Source: Zepbound and Mounjaro prescribing information (DailyMed), revised 08/2026.
The 5-day half-life is what makes once-weekly injection practical. A product that is swallowed or held under the tongue would need its own studies to show how much is absorbed and how long it lasts. Those studies are not in our list, so "oral tirzepatide dosage" has no verified answer. Any dose printed on a compounded oral product was set by that pharmacy, not by a label.
What about oral semaglutide?
An oral form of the different GLP-1 drug semaglutide does exist as an approved diabetes medicine. It is not tirzepatide, and it does not activate the GIP receptor the way tirzepatide does. If someone offers you "oral tirzepatide" and the fine print says semaglutide, you are being sold a different molecule. Our semaglutide vs tirzepatide comparison covers how the two drugs differ in the head-to-head trials.
How to take tirzepatide the labeled way
If you and a prescriber decide tirzepatide is right for you, the labeled route is a weekly injection under the skin of the abdomen, thigh or upper arm, rotating sites each week. The needle is short and the volume is small. Our injection site guide walks through it, and the Zepbound pen video shows the pen version.
What this means for compounded tirzepatide
FormBlends offers compounded tirzepatide for injection only. It is prepared by state-licensed 503A compounding pharmacies, prescribed by independent clinicians of Recess MD LLC, and shipped cold with injection supplies included. It costs $149 for the first month and $239 a month after that, at any dose, with details on the pricing page. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro. FormBlends does not offer oral, sublingual or ODT tirzepatide, because there is no evidence we can point to that those forms work. A licensed provider decides whether any compounded medication is appropriate for you; the assessment is where that decision starts.
Frequently Asked Questions
Is there a tirzepatide pill?
No approved one. Zepbound and Mounjaro are injections, and no oral tirzepatide has been FDA approved. Products sold as tirzepatide pills or capsules are compounded or unapproved and have no published trial evidence we can cite.
Does sublingual tirzepatide work?
There is no published trial in our verified sources showing that sublingual tirzepatide drops or tablets reduce weight or reach useful blood levels. The weight-loss numbers people quote come from injection trials such as SURMOUNT-1. A sublingual product has not earned those numbers.
Is oral tirzepatide as effective as injection?
Nobody can say, because no head-to-head study of an oral tirzepatide product against the injection is in the published record we use. The injection has 72-week trial data at 5, 10 and 15 mg. Oral products have none.
What is the oral tirzepatide dosage?
There is no labeled oral dose, because there is no approved oral product. The only labeled doses are the injectable ones: 2.5 mg to start, then 5, 7.5, 10, 12.5 or 15 mg once weekly as set by your prescriber. Never take a dose printed on an unapproved product without talking to a clinician.
How much does oral tirzepatide cost?
We do not print prices for oral tirzepatide because we do not offer it and cannot verify what is being sold. For comparison, FormBlends compounded injectable tirzepatide is $149 for the first month and $239 a month after, and Zepbound vials through LillyDirect self-pay run $299 to $699 a month depending on dose.
Sources
- Zepbound prescribing information, DailyMed, revised 08/2026.
- Mounjaro prescribing information, DailyMed, revised 08/2026.
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, U.S. Food and Drug Administration.
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), Jastreboff et al., New England Journal of Medicine, 2022.
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1), Rosenstock et al., Lancet, 2021.
- FormBlends pricing, Form Blends LLC, verified September 5, 2026.
Next steps
Read are tirzepatide tablets as effective as injections for the review question in more depth, or see why Mounjaro does not come in drops. Browse the tirzepatide hub for every other tirzepatide question. Talk to a licensed clinician before starting or changing any medication. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →